Where does Asana BioSciences, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Asana BioSciences, LLC ranks #9,188 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Asana BioSciences, LLC hold?

Asana BioSciences, LLC holds 34 US utility patents granted between 2015 and 2024, spanning 8 technology areas.

What is Asana BioSciences, LLC's Innovation Score?

Asana BioSciences, LLC has an Innovation Score of 37.3 out of 100 (top 44% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Asana BioSciences, LLC focus on?

Asana BioSciences, LLC's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 32 patents, ranking #610 of 6,058 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Asana BioSciences, LLC's patent grant rate increasing or decreasing?

Asana BioSciences, LLC's recent grant velocity is -38% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Asana BioSciences, LLC's patents?

Asana BioSciences, LLC's patents average 22.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Asana BioSciences, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Asana BioSciences, LLC

USPTO PatentsView assignee record - 34 granted patents across 8 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Asana ranks #9,188 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 8 technology areas.

#9,188
of 49,997 US assignees by volume: Top 44%
by Innovation Score (37.3/100): 22.2
avg claims per patent: -38%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9188 · US Corporation #9,188 · 34 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 34 grants
UPPER-Q #9,188/49,997
PHOTO-FINISH Aesynt Incorporated
CPC-NARROW A61P · 8 areas
INNOV-THIN 37.3/100
CLAIMS-DENSE 22.2 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -38% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Aesynt Incorporated (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Asana’s 37.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.3 pts (33%) Velocity 1.7 pts (5%) Breadth 10.0 pts (27%) Claim depth 13.3 pts (36%)

Qualcomm Incorporated · highest

85
Airspan Networks · near

37
Asana BioSciences · this assignee

37
Kuroda Precision… · near

37
NEC Energy Devices · near

37
Pfenex · near

37
3D Lighting… · lowest

7

What this shows Asana's Innovation Score is 37.3/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Asana?

Each dot is one of Asana’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Asana’s own 22.2 claims/patent is ABOVE the 14.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Asana vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Asana's grants concentrate

Asana BioSciences, LLC is a focused PatentsView assignee: 8 CPC subclasses with 94.1% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (7 grants) versus a trough of 2 in 2017. By volume, Asana sits between Aesynt Incorporated and Boral IP Holdings (AUSTRALIA) PTY Limited.

Asana's three-year grant acceleration

Asana BioSciences, LLC shows 4 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Aesynt Incorporat…

34
Alto-shaam

34
Apollo Endosurger…

34
Ariens

34
BIG Heart PET

34
Biomadison

34
Bizlink Internati…

34
Boral IP Holdings…

34
Asana Biosciences ◀

34

What this shows Asana holds 34 patents at rank #9,194, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Asana

By rank, the assignees closest to #9,194 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Asana's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Asana, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Asana ranks #610 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (37 here).

Kuroda Precision Industries Ltd. 37 Airspan Networks Inc. 37 NEC Energy Devices, Ltd. 37 Pfenex Inc. 37

Asana's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 44% higher than 56% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Asana BioSciences, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	14.7%
2016	5	14.7%
2017	2	5.9%
2018	2	5.9%
2019	7	20.6%
2020	7	20.6%
2021	2	5.9%
2022	2	5.9%
2024	2	5.9%

Which technologies does Asana BioSciences, LLC patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 32

C07D - Heterocyclic Compounds 30

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 24

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 3

C07K - Peptides 2

C07C - Acyclic OR Carbocyclic Compounds 1

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Asana BioSciences, LLC's patent record in context - here's where to go next.

Asana BioSciences, LLC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 94.1% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #9,188 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Asana BioSciences, LLC against Aesynt Incorporated, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.